Atlas Trials

Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy Subjects

Clinical trial NCT05523141 · COMPLETED

Trial details

NCT number
NCT05523141
Sponsor
Ascletis Pharmaceuticals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SARS CoV 2 Infection
Start date
2022-10-07
Primary completion
2022-11-18
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.